Krka d.d. (WAR:KRK) Debt-to-Asset : 0.00 (As of Sep. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Krka d.d. Debt-to-Asset?

Krka d.d.'s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was zł13 Mil. Krka d.d.'s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was zł29 Mil. Krka d.d.'s Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was zł11,092 Mil. Krka d.d.'s debt to asset for the quarter that ended in Sep. 2023 was 0.00.

Krka d.d. Debt-to-Asset Historical Data

The historical data trend for Krka d.d.'s Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka d.d. Debt-to-Asset Chart

Krka d.d. Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.01

0.05

Krka d.d. Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Krka d.d.'s Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Krka d.d.'s Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Krka d.d.'s Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka d.d.'s Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Krka d.d.'s Debt-to-Asset falls into.

Krka d.d. Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Krka d.d.'s Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(15.577	+	33.582)	/	11157.358
	=	0.00

Krka d.d.'s Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(13.38	+	28.985)	/	11092.192
	=	0.00

Krka d.d. (WAR:KRK) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Krka d.d. Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Krka d.d.'s Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Krka d.d. (WAR:KRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (WAR:KRK) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

KRKG:Slovenia 0HLK:UK

Address

Smarjeska Cesta 6, Novo Mesto, SVN, 8501

Website

https://www.krka.biz

Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.

Krka d.d. (WAR:KRK) Headlines

No Headlines